Curis (CRIS) – Hot FDA News
-
Curis (CRIS) Announces FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID
-
Curis (CRIS) Announces FDA Lifted Hold on Monotherapy Dose Escalation of Emavusertib in TakeAim Leukemia Study CRIS: Curis
-
-
-
-
-
-
-
-
Back to CRIS Stock Lookup